We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Case Study · August 29, 2020

Apremilast and Systemic Retinoid Combination Treatment for Moderate to Severe Palmoplantar Psoriasis

Cutaneous Medicine for the Practitioner

 

Additional Info

Cutaneous Medicine for the Practitioner
Apremilast and Systemic Retinoid Combination Treatment for Moderate to Severe Palmoplantar Psoriasis
Cutis 2020 Jul 01;106(1)E15-E17, T Czarnowicki, BP Rosendorff, MG Lebwohl

Further Reading